Clinical Transplantation

Papers
(The H4-Index of Clinical Transplantation is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Early effects of first‐line treatment with anti‐interleukin‐6 receptor antibody tocilizumab for chronic active antibody‐mediated rejection in kidney transplantation49
Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients44
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States42
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications38
Pig kidney xenotransplantation: Progress toward clinical trials36
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcare35
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience32
Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: A meta‐analysis31
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐1930
Convalescent plasma therapy: Helpful treatment of COVID‐19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications30
Organ donation and transplant: The Islamic perspective30
Financial impact of delayed graft function in kidney transplantation30
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review30
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study27
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine27
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database25
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant25
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe25
Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States24
A short overview on mycophenolic acid pharmacology and pharmacokinetics24
Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost23
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors23
Attenuated early inflammatory response in solid organ recipients with COVID‐1923
Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: Experience at large transplant center in New York City23
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an23
Development of the living donation and kidney transplantation information made easy (KidneyTIME) educational animations23
0.041651010513306